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www.elsevier.com/locate/bbamcrBiochimica et Biophysica ActaMeeting reportThe European Calcium Society (http://www.ulb.ac.be/
assoc/ecs/), which has become established as a leading
forum for scientists working in the area of calcium biology,
held its 9th meeting from the 19th to 22nd July 2006 at the
Illkirch University campus in Strasbourg. Delegates from
around the world enjoyed 3 days of outstanding science and
blistering heat, and organiser Jacques Haiech and his local
team deserve great credit for the hospitality and generosity of
their welcome, and for over-indulging us with the culinary
delights of Alsace.
The meeting began with a lecture from Michael Berridge
(Cambridge, UK) on calcium signaling in health and disease.
Those who have heard Mike speak on other occasions will be
familiar with his exceptional ability to coalesce and conceptua-
lise the vast expanse of research in the calcium field, and the
stunning clarity with which he presents his ideas and
hypotheses. In his opening lecture he put forward the idea
that cells utilise a toolbox of proteins, including channels,
receptors, sensors, effectors and buffers, that create, shape and
respond to calcium signals. He elaborated on this with the
suggestion that cells have a sort of built in ‘intelligence’ that
assesses the ‘quality’ of calcium signals, and which feeds back
through the regulation of gene transcription to modulate the
expression levels of toolbox components. He used this
paradigm to explain how adaptive changes in pathological
conditions such as cardiovascular disease and polycystic kidney
disease lead to aberrant calcium signaling and consequent
dysfunction at the cellular level.
Bob Williams (Oxford, UK) took us back to the beginning of
life on earth and in an engaging keynote lecture he explained
how over billions of years the transition from an anaerobic to an
aerobic world was accompanied by the emergence of calcium as
a second messenger and the inevitable evolution of calcium-
binding proteins. Developing this theme, Reg Morgan (Oviedo,
Spain) showed how the DNA sequence data that are now
available for thousands of species may be used to identify the
origins of the major families of calcium-binding proteins. He
also reported the first identification of a prokaryotic single-
repeat annexin in a phagocytic inhabitant of the Sargasso Sea,
and other evolutionary curiosities such as an eight-repeat
annexin in Amphioxus. Anni Vedeler (Bergen, Norway) also
talked about annexins, specifically annexin A2. She presented
intriguing data showing that annexin A2 is capable of binding to
its own mRNA and also to the 3′untranslated region of c-myc
mRNA.doi:10.1016/j.bbamcr.2006.09.016The S100 proteins were well represented at the meeting, and
in the first talk on this topic David Weber (Baltimore, USA)
discussed the relationship between S100B and the tumour
suppressor protein p53. In malignant melanoma elevated levels
of S100B appear to be responsible for p53 down-regulation,
presumably contributing to the ability of the tumour cells to
avoid apoptosis. Arnaud Galichet (Zurich, Switzerland) pre-
sented data on the role of S100 proteins in brain pathology, with
emphasis on the RAGE receptor and the effects of S100A6 on
cell viability. Johannes Roth (Munster, Germany) talked about
the activities of S100A8 and S100A9, and reported that acting
together, these proteins promote signaling via the toll-like
receptor 4 and NFκB activation to induce a pro-inflammatory
phenotype in vascular endothelial cells. S100B was the focus of
the presentation by Rosario Donato (Perugia, Italy), who
reported that S100B activates microglia via the RAGE pathway
and stimulation of NFκB, with consequent up-regulation of the
pro-inflammatory molecule COX-2.
A series of talks on calmodulin revealed that there is still
much to learn about the properties and functions of this
protein. Yoshinobu Izumi (Yamagata, Japan) reported the
presence of a highly conserved sequence in the cytoplasmic
domain of the viral protein GP41, that is required for
calmodulin binding and which may therefore be necessary
for viral replication. In her Keynote lecture Claude Klee
(Bethesda, USA) talked us through more than 100 years of
calcium biology, describing how the discovery of calmodulin
was a defining step. She elaborated on how experiments with
calmodulin led to the identification of the phosphatase
calcineurin, and explained using structural and biochemical
models how Ca2+, calmodulin and the subunits of calcineurin
function together to regulate the activity of the transcription
factor NFAT. Calcineurin also formed the focus of the
presentation by Robert Schultz (Houston, USA) who reported
on a key role for calcineurin-responsive transcriptional
elements in Drosophila flight muscle development. Calmodu-
lin is important not only as a regulator of phosphatase activity,
but also as an activator of a large number of kinases, and
David Watterson (Chicago, USA) described how calmodulin-
dependent kinases may be developed as targets for therapeutic
tools using approaches such as integrative chemical biology.
The role of calmodulin-dependent protein kinase II in the
nucleus was discussed by John Dedman (Cincinnati, USA),
who presented work on the development of a transgenic mouse
expressing a peptide inhibitor of this kinase specifically in the
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develop morbid features of heart disease in response to
physiological stresses such as exercise or pregnancy.
Ca2+ signaling in the nucleus remains a controversial
subject, and the regulation and function of nuclear Ca2+ fluxes
are only partly understood. Magali Savignac (Madrid, Spain)
discussed studies on the only known transcription factor to be
directly regulated by Ca2+, namely DREAM, reporting that
DREAM may act as a Ca2+-dependent repressor in T
lymphocytes. Nuclear Ca2+ signaling also featured in a
presentation by Raoul Ranjeva (Castanet-Tolosan, France),
who considered the biological implications of cytosolic and
nuclear calcium in plant cells. This was the first ECS
symposium to include talks on plant calcium signaling, with
Alistair Hetherington (Lancaster, UK) contributing to this topic
with a fascinating account of how calcium mediates abscissic
acid-dependent changes in guard cell turgor. The positive
response to these talks suggests that calcium signaling in plants
will become a regular feature of future ECS meetings.
Model organisms have provided many important insights
into the pleiotropic roles of calcium, and Andrew Miller
(Kowloon, Hong Kong) showed how the transparency of
zebrafish can be used in conjunction with an aequorin-based
imaging strategy to follow Ca2+ signaling during early
embryonic patterning. A series of elegant time-lapse movies
showed a variety of spontaneous calcium waves and stochastic
pulses in the germ layers and segments. Catherine LeClerc
(Toulouse, France) presented studies focusing on the role of
calcium in early neurogenesis in the Xenopus embryo, with data
showing that while Ca2+ is required for neural determination,
Ca2+-dependent signaling pathways are inactive during epider-
mal determination.
The diverse role of Ca2+ in the nervous system was exem-
plified in talks on NMDA receptor signaling, synaptic vesicle
priming and Alzheimer's disease. Michael Kreutz (Magdeburg,
Germany) presented his work on the functional relationship
between the calmodulin-like protein caldendrin, and a novel
protein binding partner named Jacob. Crucially, caldendrin
controls the cytosolic localisation of Jacob in a Ca2+-dependent
manner, releasing Jacob to translocate to the nucleus following
NMDA receptor-mediated elevation of Ca2+. The importance
of Ca2+ in disease was highlighted by Jacek Kuznicki (Warsaw,
Poland) who discussed both the Ca2+-dependent binding of
calmyrin to the Alzheimer's disease-associated presenilin
proteins, and recent work on the topology of presenilins in
cellular membranes. In a different disease context, Philippe
Lory (Montpellier, France) presented work on mutations in
voltage-gated Ca2+ channels that lead to diseases such as
epilepsy and Timothy Syndrome. In certain instances the
mutations were shown to lead to mis-localisation or accumula-
tion of newly synthesised receptor subunits in the cytoplasm.
Ca2+-dependent exocytotic fusion events at the synapse and
their precisely tuned regulation were featured in the talk by
Niels Brose (Goettingen, Germany). A number of proteins
involved in organising active zones at the presynaptic nerve
terminals were discussed with a special focus on munc13s,
their synaptic targeting and functions as revealed by specificmouse knock-out models. The importance of Ca2+-regulated
secretion in neuroendocrine cells was discussed by Marie-
France Bader (Strasbourg, France). Here, the emphasis was on
a crucial role of phospholipase D1 that generates phosphatidic
acid, a cone-shaped phospholipid probably required to allow
for an optimal bending of the lipid bilayer in the course of
membrane fusion.
Our understanding of the regulation of Ca2+ signaling has
taken a recent quantum leap with the discovery of the Orai and
Stim proteins that are generally agreed to be the long sought
after ICRAC Ca
2+ channel, and intracellular Ca2+ sensor that
detects store depletion. James Putney (Raleigh, USA) presented
live cell imaging experiments using total internal reflection
microscopy, that showed that following depletion of intra-
cellular Ca2+ stores, a Stim1-GFP fusion protein transiently
approaches the plasma membrane. These observations, together
with similar studies presented by Donald Gill (Baltimore,
USA), provided compelling evidence that the small family of
Stim and Orai proteins, despite having slightly different
properties and activities, function in concert to mediate Ca2+
influx in response to emptying of intracellular stores. The
speakers noted that the presence of a canonical EF hand in the
Stim1 protein signified a unification of interests for those in the
historically distinct fields of Ca2+-binding proteins and Ca2+
signaling. Frank Wuytack (Leuven, Belgium) reported on his
latest work on the SPCA-type Ca2+-ATPases that are involved
in Ca2+ homeostasis in the thapsigargin-insensitive membranes
of the Golgi apparatus. Analysis of SPCA isoforms using
siRNA in zebrafish embryos, which results in severe mal-
formations, revealed the importance of these ATPases in
vertebrate development. Further insights into the regulation of
Ca2+ signaling came from Llewelyn Roderick (Babraham, UK)
who described a role for InsP3 in the induction of cardiac
hypertrophy. In neonatal rat cardiomyocytes, high-speed
confocal imaging revealed that InsP3-induced Ca
2+ release is
spatially controlled in a manner that suggests localised
regulation of gene transcription. Andreas Guse (Hamburg,
Germany) presented work showing that nicotinic acid adenine
dinucleotide phosphate (NAADP) has an essential role in T cell
Ca2+ signaling, and further reported that a small molecule
inhibitor of NAADP exhibited beneficial therapeutic effects in
experimental autoimmune encephalomyelitis, an animal model
of multiple sclerosis.
There were several reports of new investigations into the
functions of certain Ca2+-binding proteins. Masatoshi Maki
and Hironori Suzuki (Nagoya, Japan) discussed the penta-EF
hand protein ALG-2, and showed using mutagenesis and
recombinant expression of specific domains that different
parts of the ALG-2 molecule are involved in mediating
interactions with Alix and phospholipid scramblase 3.
Feihan Dai (Toronto, Canada) presented her work on the
visinin-like protein VILIP-1, reporting that in pancreatic β-
cells VILIP-1 has an inhibitory effect on insulin secretion via
regulation of the insulin transactivator Pdx1. The way in which
Ca2+-regulated proteins are organised and assembled in the
sarcoplasmic reticulum of skeletal muscle cells was addressed
by Vincenzo Sorrentino (Siena, Italy). Using fluorescence
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GFP fusions of ank1.5, triadin and SERCA, dramatic
SERCA, dramatic differences were observed in the intracel-
lular mobility of these proteins during the organisation of
SR domains. Jenny Yang (Atlanta, USA) brought the
meeting to a conclusion with her work on the rational
design of Ca2+ -binding proteins using bioinformatics and
protein modeling. Despite the technical challenge she
presented work suggesting that this approach may in time
yield a Ca2+-sensitive GFP.Stephen E. Moss
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